Transient Receptor Potential
The largest group of receptors that function as noxious stimuli detectors in nociceptors is the transient receptor potential (TRP) channel family. TRPs have been subclassified into the C, V, M, A, P, and ML subfamilies. The members are principal transducers of thermal stimuli that depolarize nerve terminals to the action potential threshold. A role of TRP channels specifically in pain and thermosensation was first suggested by the finding that mammalian TRPV1 is activated by both noxious heat and capsaicin, the active ingredient of chilli peppers. Although there is little amino-acid conservation among distant TRP channels, they share a similar architecture of six-transmembrane domains with cytoplasmic amino and carboxy termini. TRP channels are thought to function as tetramers, mostly as homomers. Six of the 28 TRP channels from the three distinct TRP family subtypes are activated by temperature (TRPV1–4, TRPM8 and TRPA1). Three other TRP channels (TRPM2, TRPM4 and TRPM5) are strongly modulated by warm temperatures as well; however, the lack of expression in nociceptor neurons argues against a role in nociception[1].
[1] A. Patapoutian et al. Transient receptor potential channels: targeting pain at the source. Nat Rev Drug Discov. 2009 Jan;8(1):55-68.
Axon ID | Name | Description | From price | |
---|---|---|---|---|
1816 | A 784168 | TRPV1 receptor antagonist | €95.00 | |
1504 | ABT 102 | TRPV1 antagonist | €90.00 | |
3026 | AC1903 | Selective TRPC5 inhibitor | €95.00 | |
3356 | AMG 9810 | Potent and selective vanilloid receptor-1 (TRPV1) antagonist | €90.00 | |
3036 | BI 749327 | Potent, selective and orally bioavailable TRPC6 inhibitor | €160.00 | |
2458 | Clemizole | Inhibitor of the transient receptor potential channel TRPC5 | €75.00 | |
2742 | GSK 2193874 | Orally active TRPV4 antagonist | €120.00 | |
3726 | JT010 | Potent and selective TRPA1 agonist | €90.00 | |
2423 | M8-B hydrochloride | Selective and potent antagonist of the TRPM8 channel | €115.00 | |
2980 | ML2-SA1 | Potent and selective activator of TRPML2 | €105.00 | |
3349 | NMDAR-TRPM4 blocker C19 dihydrochloride | NMDAR/TRPM4 interaction interface inhibitor | €130.00 | |
3348 | NMDAR-TRPM4 blocker C8 dihydrochloride | NMDAR/TRPM4 interaction interface inhibitor | €120.00 | |
3633 | Ononetin | Potent and selective TRPM3 antagonist | €60.00 | |
2374 | Optovin | Reversible photoactivated TRPA1 agonist | €85.00 | |
2483 | PF 05105679 | TRPM8 inhibitor with >100-fold selectivity and in vivo activity in humans | €95.00 | |
2498 | RQ 00203078 | Selective, potent, and orally active TRPM8 antagonist with in vivo activity | €125.00 | |
3287 | SET2 | Potent and selective TRPV2 inhibitor | €100.00 | |
4100 | TRPML3 activator SN2 | First selective TRPML3 activator | Recently added | €105.00 |
4226 | TRPV1 antagonist CX-3 | First-in-class highly selective TRPV1 antagonist | Recently added | €90.00 |